Conserved Helix 7 Tyrosine Acts as a Multistate Conformational Switch in the 5HT2C Receptor

Studies in many rhodopsin-like G-protein-coupled receptors are providing a general scheme of the structural processes underlying receptor activation. Microdomains in several receptors have been identified that appear to function as activation switches. However, evidence is emerging that these receptor proteins exist in multiple conformational states. To study the molecular control of this switching process, we investigated the function of a microdomain involving the conserved helix 7 tyrosine in the serotonin 5HT2C receptor. This tyrosine of the NPXXY motif was substituted for all naturally occurring amino acids. Three distinct constitutively active receptor phenotypes were found: moderate, high, and “locked-on” constitutive activity. In contrast to the activity of the other receptor mutants, the high basal signaling of the locked-on Y7.53N mutant was neither increased by agonists nor decreased by inverse agonists. The Y7.53F mutant was uncoupled. Computational modeling based on the rhodopsin crystal structure suggested that Y7.53 interacts with the conserved aromatic ring at position 7.60 in the recently identified helix 8 domain. This provided a basis for seeking revertant mutations to correct the defective function of the Y7.53F receptor. When the Y7.53F receptor was mutated at position 7.60, the wild-type phenotype was restored. These results suggest that Y7.53 and Y7.60 contribute to a common functional microdomain connecting helices 7 and 8 that influences the switching of the 5HT2C receptor among multiple active and inactive conformations.

[1]  U. Kumar,et al.  The Cytoplasmic Tail of the Human Somatostatin Receptor Type 5 Is Crucial for Interaction with Adenylyl Cyclase and in Mediating Desensitization and Internalization* , 1998, The Journal of Biological Chemistry.

[2]  L. Slice,et al.  The conserved NPXnY motif present in the gastrin-releasing peptide receptor is not a general sequestration sequence. , 1994, The Journal of biological chemistry.

[3]  B. Kobilka,et al.  Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations. , 2001, The Journal of pharmacology and experimental therapeutics.

[4]  L. Hunyady,et al.  A Conserved NPLFY Sequence Contributes to Agonist Binding and Signal Transduction but Is Not an Internalization Signal for the Type 1 Angiotensin II Receptor (*) , 1995, The Journal of Biological Chemistry.

[5]  E. sanders-Bush,et al.  Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. , 1995, Molecular pharmacology.

[6]  E. Freire,et al.  The propagation of binding interactions to remote sites in proteins: analysis of the binding of the monoclonal antibody D1.3 to lysozyme. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Payan,et al.  Identification of Potential Tyrosine-containing Endocytic Motifs in the Carboxyl-tail and Seventh Transmembrane Domain of the Neurokinin 1 Receptor* , 1997, The Journal of Biological Chemistry.

[8]  S. Miura,et al.  Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn(111). , 1998, Biochemistry.

[9]  H. Weinstein,et al.  The Functional Microdomain in Transmembrane Helices 2 and 7 Regulates Expression, Activation, and Coupling Pathways of the Gonadotropin-releasing Hormone Receptor* , 1999, The Journal of Biological Chemistry.

[10]  P Ghanouni,et al.  Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic Receptor* , 2001, The Journal of Biological Chemistry.

[11]  J W Saldanha,et al.  Transmembrane Domains 4 and 7 of the M1Muscarinic Acetylcholine Receptor Are Critical for Ligand Binding and the Receptor Activation Switch* , 2001, The Journal of Biological Chemistry.

[12]  K. Hofmann,et al.  Two different forms of metarhodopsin II: Schiff base deprotonation precedes proton uptake and signaling state. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Maigret,et al.  Control of Conformational Equilibria in the Human B2 Bradykinin Receptor , 2001, The Journal of Biological Chemistry.

[14]  S. Nickolls,et al.  Agonist Regulation of D2 Dopamine Receptor/G Protein Interaction , 2001, The Journal of Biological Chemistry.

[15]  Harel Weinstein,et al.  Three-dimensional representations of G protein-coupled receptor structures and mechanisms. , 2002, Methods in enzymology.

[16]  R. Leduc,et al.  The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization. , 1996, Molecular pharmacology.

[17]  R. Nussinov,et al.  Folding funnels and binding mechanisms. , 1999, Protein engineering.

[18]  W. C. Probst,et al.  Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.

[19]  M. Grotewiel,et al.  Differences in agonist-independent activity of 5-HT2A and 5-HT2C receptors revealed by heterologous expression , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[20]  Elaine C. Meng,et al.  An Activation Switch in the Ligand Binding Pocket of the C5a Receptor* , 2001, The Journal of Biological Chemistry.

[21]  M. Caron,et al.  Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. , 1992, The Journal of biological chemistry.

[22]  M. Brann,et al.  The Second Intracellular Loop of the m5 Muscarinic Receptor Is the Switch Which Enables G-protein Coupling* , 1998, The Journal of Biological Chemistry.

[23]  O. Lichtarge,et al.  Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F , 1996, Nature.

[24]  H Weinstein,et al.  Related Contribution of Specific Helix 2 and 7 Residues to Conformational Activation of the Serotonin 5-HT2A Receptor (*) , 1995, The Journal of Biological Chemistry.

[25]  J. Wess,et al.  Conformational Changes That Occur during M3Muscarinic Acetylcholine Receptor Activation Probed by the Use of an in Situ Disulfide Cross-linking Strategy* , 2002, The Journal of Biological Chemistry.

[26]  O. Lichtarge,et al.  Similar structures and shared switch mechanisms of the beta2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation. , 1999, The Journal of biological chemistry.

[27]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[28]  K. Palczewski,et al.  Activation of rhodopsin: new insights from structural and biochemical studies. , 2001, Trends in biochemical sciences.

[29]  R. Zare,et al.  Single-molecule spectroscopy of the β2 adrenergic receptor: Observation of conformational substates in a membrane protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Hulme,et al.  A Network of Conserved Intramolecular Contacts Defines the Off-state of the Transmembrane Switch Mechanism in a Seven-transmembrane Receptor* , 2000, The Journal of Biological Chemistry.

[31]  T. Gudermann,et al.  A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G‐protein coupling , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  J. Dias,et al.  Structural biology of human follitropin and its receptor. , 2001, Archives of medical research.

[33]  R. Graham,et al.  Phe(303) in TMVI of the alpha(1B)-adrenergic receptor is a key residue coupling TM helical movements to G-protein activation. , 2002, Biochemistry.

[34]  J. Stankova,et al.  Structural and Functional Requirements for Agonist-induced Internalization of the Human Platelet-activating Factor Receptor* , 1997, The Journal of Biological Chemistry.

[35]  P Ghanouni,et al.  Agonist-induced conformational changes in the G-protein-coupling domain of the β2 adrenergic receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Ballesteros,et al.  Structural motifs as functional microdomains in G-protein-coupled receptors: Energetic considerations in the mechanism of activation of the serotonin 5-HT2A receptor by disruption of the ionic lock of the arginine cage* , 2002 .

[37]  H Weinstein,et al.  Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp. , 2001, Biochemistry.

[38]  H Weinstein,et al.  Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor , 1997, The EMBO journal.

[39]  K Konvicka,et al.  A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. , 1994, Molecular pharmacology.

[40]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[41]  D C Teller,et al.  Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.

[42]  A. Fersht,et al.  Protein engineering and the study of structure--function relationships in receptors. , 1990, Trends in pharmacological sciences.

[43]  T. Schwartz,et al.  Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Caron,et al.  A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration. , 1994, The Journal of biological chemistry.

[45]  J. Saldanha,et al.  Seven-transmembrane receptors: crystals clarify. , 2002, Trends in pharmacological sciences.

[46]  K. Konvička,et al.  A proposed structure for transmembrane segment 7 of G protein-coupled receptors incorporating an asn-Pro/Asp-Pro motif. , 1998, Biophysical journal.

[47]  P. Leff,et al.  Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. , 1998, Molecular pharmacology.

[48]  R. Vogel,et al.  Conformation and stability of alpha-helical membrane proteins. 1. Influence of salts on conformational equilibria between active and Inactive states of rhodopsin. , 2002, Biochemistry.

[49]  J. Anderson,et al.  A mutation in the hamster alpha1B-adrenergic receptor that differentiates two steps in the pathway of receptor internalization. , 1997, Molecular pharmacology.

[50]  A. Jesaitis,et al.  Identification of Putative Sites of Interaction between the Human Formyl Peptide Receptor and G Protein* , 1999, The Journal of Biological Chemistry.

[51]  M. Caron,et al.  The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta 2-adrenergic receptor. , 1995, Biochemistry.

[52]  A. Saltzman,et al.  Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. , 1991, Biochemical and biophysical research communications.

[53]  H. Weinstein,et al.  Constitutive activation of the mu opioid receptor by mutation of D3.49(164), but not D3.32(147): D3.49(164) is critical for stabilization of the inactive form of the receptor and for its expression. , 2001, Biochemistry.

[54]  J. Ballesteros,et al.  Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.

[55]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[56]  M. Struthers,et al.  G protein-coupled receptor activation: analysis of a highly constrained, "straitjacketed" rhodopsin. , 2000, Biochemistry.

[57]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[58]  Martin J. Lohse,et al.  Mutations of Tyr326 in the β2-adrenoceptor disrupt multiple receptor functions , 1996 .

[59]  C. Chew,et al.  Lasp-1 is a regulated phosphoprotein within the cAMP signaling pathway in the gastric parietal cell. , 1998, American journal of physiology. Cell physiology.

[60]  Robert P. Millar,et al.  Functional Microdomains in G-protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[61]  G. Liapakis,et al.  Constitutive Activation of the β2 Adrenergic Receptor Alters the Orientation of Its Sixth Membrane-spanning Segment* , 1997, The Journal of Biological Chemistry.

[62]  J. Ballesteros,et al.  Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. , 2001, Molecular pharmacology.

[63]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[64]  E. sanders-Bush,et al.  Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands. , 1994, The Journal of biological chemistry.

[65]  Bryan L Roth,et al.  Evidence for a Model of Agonist-induced Activation of 5-Hydroxytryptamine 2A Serotonin Receptors That Involves the Disruption of a Strong Ionic Interaction between Helices 3 and 6* 210 , 2002, The Journal of Biological Chemistry.

[66]  Alan R. Fersht,et al.  The use of double mutants to detect structural changes in the active site of the tyrosyl-tRNA synthetase (Bacillus stearothermophilus) , 1984, Cell.

[67]  Marvin Wickens,et al.  Analyzing mRNA-protein complexes using a yeast three-hybrid system. , 2002, Methods.

[68]  S. Sealfon,et al.  Conserved helix 7 tyrosine functions as an activation relay in the serotonin 5HT(2C) receptor. , 2000, Brain research. Molecular brain research.

[69]  H. Weinstein,et al.  Molecular Dynamics Simulation of Membranes and a Transmembrane Helix , 1999 .

[70]  Y. Shichida,et al.  Heterogeneity of rhodopsin intermediate state interacting with transducin. , 2000, Methods in enzymology.

[71]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[72]  D. Oprian,et al.  Transducin activation by rhodopsin without a covalent bond to the 11-cis-retinal chromophore , 1991, Science.

[73]  T. Kenakin,et al.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. , 1995, Trends in pharmacological sciences.